Archived Information for COVID-19 Vaccine Providers
December 2021
- 12/21/21 - Pfizer COVID-19 vaccine Tris Sucrose Adult/Adolescent Formulation (gray cap) ordering, storage, handling
- 12/21/21 - Replenishing Dry Ice for Pfizer BioNTech COVID-19 Vaccine
- 12/02/21 - Guidance for Healthcare Providers: COVID-19 treatment options
November 2021
- 11/19/21 - COVID-19 Vaccine Communications Toolkit
- 11/16/21 - COVID-19 Vaccine Ordering Webinar
- 11/15/21 - Ohio Vax-2-School posters
- 11/04/20 - General Guidance for COVID-19 Second Dose
- 11/01/21 - COVID-19 Vaccine Pediatric Vaccine Overview and How to Order Doses Through VOMS (Powerpoint)
July 2021
- 07/29/21 - Johnson & Johnson shelf life extended
June 2021
- 06/16/21 - Invitation to ACS and Ohio AAP Webinar: The Impact of COVID-19 Disease on HPV Vaccination Rates
May 2021
- 05/24/21 - Provider Guidance on Maximizing Vaccinations while Minimizing Wasted Doses
- 05/22/21 - Ohio Vax-a-Million Communications Toolkit
- 05/22/21 - Pfizer COVID-19 vaccine can be stored longer at refrigerator temperatures
- 05/03/21 - Webinar for Ohio Healthcare Providers Receiving Vaccine for the First Time
- 05/02/21 - Test Kit Disposal Guidance
April 2021
- 04/24/21 - Guidance for vaccine providers to ensure vaccine is not wasted
- 04/24/21 - Guidance for Vaccine Providers to Minimize Vaccine Wastage
- 04/23/21 - Guidance for Providers on COVID-19 Vaccine Second Doses
- 04/23/21 - Vaccine Providers Permitted to Resume Johnson & Johnson Vaccinations in Ohio
- 04/23/21 - Guidance for Providers on COVID-19 Vaccine Second Doses
- 04/19/21 - Provider Guidance on Vaccine Administration Fees
- 04/19/21 - VAERS Provider Responsibilities
- 04/13/21 - All Ohio COVID-19 vaccine providers to temporarily pause using Johnson & Johnson (Janssen) vaccine
March 2021
- 03/26/21 - Janssen Vaccine Provider Fact Sheet
- 03/17/21 - A Letter on Data Quality from ODH's Kathleen Madden and Jamie Carmichael
- 03/16/21 - Phase 1E Guidance for Providers
- 03/16/21 - Phase 2C Guidance for Providers
- 04/09/21 - Phase 2D Guidance for Providers
- 03/08/21 - Phase 2A Guidance for Providers
- 03/08/21 - Phase 2B Guidance for Providers
- 03/08/21 - Phase 1C Guidance for Providers
- 03/08/21 - Phase 1D Guidance for Providers
February 2021
- 02/18/21 - Guidance for Providers on Phase 1B Medical Conditions
- 02/16/21 - COVID-19 Vaccine Guidance to Transport to Homebound
- 02/16/21 - Guidance for Providers on Maximizing Doses of Pfizer-BioNTEch COVID-19 Vaccine
- 02/15/21 : Important message for Provider Partners Please see: Weather May Cause Delay of Vaccine Shipments from Monday, February 15, 2021
- 02/12/21 - Guidance on Phase1B of COVID-19 Vaccine Distribution
- 02/12/21 - Vaccinating Ohioans with Qualifying Medical Conditions Webinar Slides for Phase 1
- 02/24/20 - Overview of Shipments from the RSS Warehouse
- 02/10/21 - VMS Fact Sheet
- 02/08/21 - Frequently Asked Questions (FAQ)
- 02/05/21 - Overview of the VMS: slide deck presentation for providers
January 2021
- 01/24/21- Phase 1B Guidance for Local Health Departments
- 01/15/21 - Vaccine Provider Best Practices
- 01/15/21 - Reporting Covid-19 Vaccinations to ODH via ImpactSIIS: Options during Phase 1A
- 01/15/21 - ImpactSIIS Reporting Webinar Slides: Phase 1A
- 01/15/21 - ImpactSIIS Frequently Asked Questions for Phase 1B
- 01/15/21 - ImpactSIIS Reporting Webinar Slides: Phase 1B
- 01/08/21 - COVID-19 Vaccine Billing FAQ
November 2020
- 11/20/20 - EUA & VIS Information (PDF) Overview of the COVID-19 Emergency Use Authorization (EUA) and Vaccine Information Statement (VIS) information